Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Bernard Moss

SPI-1 Is a Missing Host-Range Factor Required for Replication of the Attenuated Modified Vaccinia Ankara (MVA) Vaccine Vector in Human Cells

PLoS Pathogens

English

Deletion of the Vaccinia Virus I2 Protein Interrupts Virion Morphogenesis, Leading to Retention of the Scaffold Protein and Mislocalization of Membrane-Associated Entry Proteins

English

Attenuation and Immunogenicity of Host-Range Extended Modified Vaccinia Virus Ankara Recombinants

English

Interaction Between the G3 and L5 Proteins of the Vaccinia Virus Entry–fusion Complex

Virology

2011

English

New Vaccinia Virus Recombination Plasmids Incorporating a Synthetic Late Promoter for High Level Expression of Foreign Proteins

Nucleic Acids Research

Genetics

1990

English

Dinucleotide Sequences at the 5′ Ends of Vaccinia Virus mRNA's Synthesized in Vitro

English

Physical and Functional Interactions Between Vaccinia Virus F10 Protein Kinase and Virion Assembly Proteins A30 and G7

English

Overcoming Immunity to a Viral Vaccine by DNA Priming Before Vector Boosting

English

Vaccinia Virus G7L Protein Interacts With the A30L Protein and Is Required for Association of Viral Membranes With Dense Viroplasm to Form Immature Virions

English

Induction of AIDS Virus-Specific CTL Activity in Fresh, Unstimulated Peripheral Blood Lymphocytes From Rhesus Macaques Vaccinated With a DNA Prime/Modified Vaccinia Virus Ankara Boost Regimen

Journal of Immunology

Allergy

Immunology

2000

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Bernard Moss

SPI-1 Is a Missing Host-Range Factor Required for Replication of the Attenuated Modified Vaccinia Ankara (MVA) Vaccine Vector in Human Cells

Deletion of the Vaccinia Virus I2 Protein Interrupts Virion Morphogenesis, Leading to Retention of the Scaffold Protein and Mislocalization of Membrane-Associated Entry Proteins

Attenuation and Immunogenicity of Host-Range Extended Modified Vaccinia Virus Ankara Recombinants

Interaction Between the G3 and L5 Proteins of the Vaccinia Virus Entry–fusion Complex

New Vaccinia Virus Recombination Plasmids Incorporating a Synthetic Late Promoter for High Level Expression of Foreign Proteins

Dinucleotide Sequences at the 5′ Ends of Vaccinia Virus mRNA's Synthesized in Vitro

Physical and Functional Interactions Between Vaccinia Virus F10 Protein Kinase and Virion Assembly Proteins A30 and G7

Overcoming Immunity to a Viral Vaccine by DNA Priming Before Vector Boosting

Vaccinia Virus G7L Protein Interacts With the A30L Protein and Is Required for Association of Viral Membranes With Dense Viroplasm to Form Immature Virions

Induction of AIDS Virus-Specific CTL Activity in Fresh, Unstimulated Peripheral Blood Lymphocytes From Rhesus Macaques Vaccinated With a DNA Prime/Modified Vaccinia Virus Ankara Boost Regimen